HOPCo Announces Acquisition of Digital Health Platform, MyACTome
The latest addition to HOPCo’s integrated digital health portfolio will improve patient outcomes and greatly reduce healthcare costs through AI
Phoenix, AZ (December 6, 2023) – HOPCo (Healthcare Outcomes Performance Company), the leader in musculoskeletal (MSK) clinical outcomes management solutions and the country’s largest orthopedic value-based care organization, continues its digital health platform expansion with its acquisition of MyACTome.
As the only validated smartphone-based fall risk and frailty assessment platform, MyACTome leverages the existing motion sensors within a smartphone to assess patient balance, walking dynamics, and dynamic stability patterns to quantify patient biomechanical performance, frailty score, and fall risk – allowing risk stratification of patients. Given that each year in the U.S. alone, more than $50 billion is spent on medical costs related to older adult falls, integrated technologies such as MyACTome represent a massive opportunity to improve patient safety while lowering avoidable injuries and musculoskeletal costs on a large scale.
Using the MyACTome digital solution, patient assessments are quickly performed in the clinic or at home without the need for external sensors or expensive equipment, with results available instantly to the care team through web-based dashboards. Hundreds of thousands of assessments have been performed with MyACTome using nothing more than a smartphone.
The proprietary MyACTome dynamic stability algorithms used for fall risk prediction have been extensively validated in dozens of peer-reviewed scientific publications by Dr. Thurmon Lockhart, Professor of Biomedical Engineering at Arizona State University and international leader in fall risk prediction and human movement science. The dynamic stability of human movement provides a “digital fingerprint” of each patient’s neuromuscular control and musculoskeletal coordination as an indicator not only of fall risk, overall frailty, and potentially other health conditions such as early detection of movement disorders (e.g. Parkinson’s disease), which can better inform healthcare decision making.
“The addition of MyACTome’s proven technologies to HOPCo’s digital health ecosystem is a significant advancement in our ability to improve patient safety and identify those patients most at risk for costly falls and complications, many of which represent a largely avoidable burden on our national healthcare system,” said Rina Vertes, President of Value-Based Care Solutions at HOPCo.
“The ability to now easily and rapidly identify and risk stratify patients very early and deploy targeted exercises and other modalities right to their smartphone to measurably reduce their complications and fall risk is really exciting,” added Dr. Wael Barsoum, Chief Transformation Officer at HOPCo.
MyACTome is being integrated into HOPCo’s existing and proven digital health offering, which includes HOPCo’s msk.ai patient engagement and quality outcomes tracking platform. This allows for real-time individual patient care pathway customization, all tracked through a centralized data system and reported to the clinical team. Furthermore, HOPCo’s digital health portfolio, combined with its already deployed and extensive claims analytics, medical economics, and value-based care programs across the U.S. will enhance HOPCo’s ability to improve patient outcomes, target those patients who are at greatest risk of avoidable injuries and complications, and drive additional savings and value across the MSK care continuum.
About Healthcare Outcomes Performance Company (HOPCo)
Healthcare Outcomes Performance Company (HOPCo) is the national leader of integrated musculoskeletal value-based health outcomes management, practice management and health system service line management. This includes comprehensive expertise across all MSK specialties, including orthopedics, spine, neurosurgery, hand, pain management, rehabilitation and neurology. HOPCo’s integrated care, analytics, and facilities development and management platforms have proven to increase the quality of patient care while reliably reducing the total cost of care across the care continuum for practices, health systems and payors alike. HOPCo’s affiliated payors, practices, and health systems successfully participate in highly efficient value-based contracting (bundled payments, chronic episodes of care initiatives, population health programs, and other advanced risk-based arrangements) utilizing HOPCo’s proprietary platforms, IT solutions, digital patient engagement platform, integrated analytics, and evidence-based comprehensive care pathways. Visit www.hopco.com to learn more.
###
For media inquiries, please contact:
Daniel Goldberg
Sr. Vice President of Marketing and Communications
Healthcare Outcomes Performance Company (HOPCo)
623.241.8649
Daniel.Goldberg@hopco.com